We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Court Tosses Securities Fraud Charges Against ICN

Law360 (June 21, 2006, 12:00 AM EDT) -- In a turnaround for ICN Pharmaceuticals, a federal appeals court has affirmed a lower court’s dismissal of securities fraud allegations brought in a class action more than two years ago, even as the company’s ousted founder has filed his own suit accusing his successors of intentionally driving down stock prices.

A group of investors originally filed the charges in 2003, alleging that top executives of ICN Pharmaceuticals (now Valeant Pharmaceuticals)—including its contentious former leader, Milan Panic—artificially inflated the company’s earnings through methods such as channel stuffing...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.